Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 11/2016

02.09.2016 | Original Article – Cancer Research

Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model

verfasst von: Veria Khosrawipour, Tanja Khosrawipour, Alexander Jens Peter Kern, Aras Osma, Burak Kabakci, David Diaz-Carballo, Eckart Förster, Jürgen Zieren, Khashayar Fakhrian

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel approach delivering intraperitoneal chemotherapy by means of a pressurized aerosol. This study was conducted to evaluate the distribution pattern of doxorubicin in the abdominal cavity after PIPAC in a postmortem swine model.

Methods

Doxorubicin was aerosolized through a Micropump© (MIP) into the peritoneal cavity of two swines at a pressure of 12 mm Hg CO2 and 32 °C. To measure the distribution of the drug, 9 different positions within the abdominal cavity were sampled. In-tissue doxorubicin penetration was evaluated using fluorescence microscopy on frozen thin sections.

Results

A maximum of drug penetration was observed in the area around the MIP. The penetration in the small intestine reached a depth of 349 ± 65 µm. Penetration depth in the right upper abdomen and left upper abdomen were 349 ± 65 and 140 µm ± 26 µm, respectively. Distant areas to the MIP showed variable penetration rates between 50 and 150 µm.

Conclusions

Doxorubicin reached all areas within the peritoneum. Highest penetration rates were measured in the area around the Micropump. Further studies are warranted to evaluate and optimize the distribution and penetration of cytotoxic agent into the tissue after PIPAC.
Literatur
Zurück zum Zitat Al-Quteimat OM, Al-Badaineh MA (2014) Intraperitoneal chemotherapy: rationale, applications, and limitations. J Oncol Pharm Pract 20(5):369–380PubMedCrossRef Al-Quteimat OM, Al-Badaineh MA (2014) Intraperitoneal chemotherapy: rationale, applications, and limitations. J Oncol Pharm Pract 20(5):369–380PubMedCrossRef
Zurück zum Zitat Chua TC, Esquivel J, Pelz JO, Morris DL (2013) Summary of current therapeutic options for peritoneal metastases from colorectal cancer. J Surg Oncol 107(6):566–573PubMedCrossRef Chua TC, Esquivel J, Pelz JO, Morris DL (2013) Summary of current therapeutic options for peritoneal metastases from colorectal cancer. J Surg Oncol 107(6):566–573PubMedCrossRef
Zurück zum Zitat Dedrick RL, Myers CE, Bungay PM, De Vita VT Jr. (1978) Pharmacokinetic rational for the peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62(1):1–11PubMed Dedrick RL, Myers CE, Bungay PM, De Vita VT Jr. (1978) Pharmacokinetic rational for the peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep 62(1):1–11PubMed
Zurück zum Zitat Demtröder C, Solass W, Zieren J, Strumberg D, Giger-Pabst U, Reymond MA (2016) Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis 18(4):364–371PubMedCrossRef Demtröder C, Solass W, Zieren J, Strumberg D, Giger-Pabst U, Reymond MA (2016) Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis. Colorectal Dis 18(4):364–371PubMedCrossRef
Zurück zum Zitat Esquis P, Consolo D, Magnin G et al (2006) High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg 244(1):106–112PubMedPubMedCentralCrossRef Esquis P, Consolo D, Magnin G et al (2006) High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis. Ann Surg 244(1):106–112PubMedPubMedCentralCrossRef
Zurück zum Zitat Flessner MF (2005) The transport barrier in intraperitoneal therapy. Am J Physiol Renal Physiol 288(3):433–442CrossRef Flessner MF (2005) The transport barrier in intraperitoneal therapy. Am J Physiol Renal Physiol 288(3):433–442CrossRef
Zurück zum Zitat Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D (2008) Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol 15(1):339–344PubMedCrossRef Gesson-Paute A, Ferron G, Thomas F, de Lara EC, Chatelut E, Querleu D (2008) Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol 15(1):339–344PubMedCrossRef
Zurück zum Zitat Jacquet P, Stuart OA, Chang D, Sugarbaker PH (1996) Effects of intraabdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs 7(5):596–603PubMedCrossRef Jacquet P, Stuart OA, Chang D, Sugarbaker PH (1996) Effects of intraabdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs 7(5):596–603PubMedCrossRef
Zurück zum Zitat Kakchekeeva T, Demtröder C, Herath NI et al (2016) In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Ann Surg Oncol (Epub ahead of print) Kakchekeeva T, Demtröder C, Herath NI et al (2016) In vivo feasibility of electrostatic precipitation as an adjunct to pressurized intraperitoneal aerosol chemotherapy (ePIPAC). Ann Surg Oncol (Epub ahead of print)
Zurück zum Zitat Khosrawipour V, Khosrawipour T, Falkenstein TA et al (2016a) Evaluating the effect of Micropump© position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. Anticancer Res (Accepted for publication on 12 July 2016) Khosrawipour V, Khosrawipour T, Falkenstein TA et al (2016a) Evaluating the effect of Micropump© position, internal pressure and doxorubicin dosage on efficacy of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. Anticancer Res (Accepted for publication on 12 July 2016)
Zurück zum Zitat Khosrawipour V, Bellendorf A, Khosrawipour T et al (2016b) Irradiation does not increase the penetration depth of doxorubicin in normal tissue after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. In Vivo 30(5):593–597PubMed Khosrawipour V, Bellendorf A, Khosrawipour T et al (2016b) Irradiation does not increase the penetration depth of doxorubicin in normal tissue after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in an ex vivo model. In Vivo 30(5):593–597PubMed
Zurück zum Zitat Khosrawipour V, Giger-Pabst U, Khosrawipour T et al (2016c) Effect of irradiation on tissue penetration depth of doxorubicin after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in a novel ex vivo model. J Cancer 7(8):910–914PubMedPubMedCentralCrossRef Khosrawipour V, Giger-Pabst U, Khosrawipour T et al (2016c) Effect of irradiation on tissue penetration depth of doxorubicin after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in a novel ex vivo model. J Cancer 7(8):910–914PubMedPubMedCentralCrossRef
Zurück zum Zitat Lotti M, Capponi MG, Piazzalunga D, Poisasina E, Pisano M, Manfredi R, Anssloni L (2016) Laparoscopic HIPEC: a bridge between open and closed-techniques. J Minim Access Surg 12(1):86–89PubMedPubMedCentralCrossRef Lotti M, Capponi MG, Piazzalunga D, Poisasina E, Pisano M, Manfredi R, Anssloni L (2016) Laparoscopic HIPEC: a bridge between open and closed-techniques. J Minim Access Surg 12(1):86–89PubMedPubMedCentralCrossRef
Zurück zum Zitat Nadiradze G, Giger-Pabst U, Zieren J, Strumberg D, Solass W, Reymond MA (2016) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis. J Gastrointest Surg 20(2):367–373PubMedCrossRef Nadiradze G, Giger-Pabst U, Zieren J, Strumberg D, Solass W, Reymond MA (2016) Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis. J Gastrointest Surg 20(2):367–373PubMedCrossRef
Zurück zum Zitat Reymond MA, Solaß W (2014) Pressurized intraperitoneal aerosol chemotherapy—cancer under pressure, 1st edn. De Gruyter, Berlin Reymond MA, Solaß W (2014) Pressurized intraperitoneal aerosol chemotherapy—cancer under pressure, 1st edn. De Gruyter, Berlin
Zurück zum Zitat Sadeghi M, Arvieux C, Glehen O et al (2000) Peritoneal carcinomatosis from non-gynecological malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358–363PubMedCrossRef Sadeghi M, Arvieux C, Glehen O et al (2000) Peritoneal carcinomatosis from non-gynecological malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358–363PubMedCrossRef
Zurück zum Zitat Solaß W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA (2012a) Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc 26:1849–1855PubMedCrossRef Solaß W, Hetzel A, Nadiradze G, Sagynaliev E, Reymond MA (2012a) Description of a novel approach for intraperitoneal drug delivery and the related device. Surg Endosc 26:1849–1855PubMedCrossRef
Zurück zum Zitat Solass W, Herbette A, Schwarz T, Hetzel A, Sun JS, Dutreix M, Reymond MA (2012b) Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc 26(3):847–852PubMedCrossRef Solass W, Herbette A, Schwarz T, Hetzel A, Sun JS, Dutreix M, Reymond MA (2012b) Therapeutic approach of human peritoneal carcinomatosis with Dbait in combination with capnoperitoneum: proof of concept. Surg Endosc 26(3):847–852PubMedCrossRef
Zurück zum Zitat Solass W, Kerb R, Mürdter T et al (2014) Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 21(2):553–559PubMedCrossRef Solass W, Kerb R, Mürdter T et al (2014) Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 21(2):553–559PubMedCrossRef
Zurück zum Zitat Sugarbaker PH (2003) Peritoneal carcinomatosis: Is cure an option? J Clin Oncol 21(5):762–764PubMedCrossRef Sugarbaker PH (2003) Peritoneal carcinomatosis: Is cure an option? J Clin Oncol 21(5):762–764PubMedCrossRef
Zurück zum Zitat Tempfer CB, Rezniczek GA, Ende P, Solass W, Reymond MA (2015) Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin in women with peritoneal carcinomatosis: a cohort study. Anticancer Res 35(12):6723–6729PubMed Tempfer CB, Rezniczek GA, Ende P, Solass W, Reymond MA (2015) Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin in women with peritoneal carcinomatosis: a cohort study. Anticancer Res 35(12):6723–6729PubMed
Metadaten
Titel
Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model
verfasst von
Veria Khosrawipour
Tanja Khosrawipour
Alexander Jens Peter Kern
Aras Osma
Burak Kabakci
David Diaz-Carballo
Eckart Förster
Jürgen Zieren
Khashayar Fakhrian
Publikationsdatum
02.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 11/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-016-2234-0

Weitere Artikel der Ausgabe 11/2016

Journal of Cancer Research and Clinical Oncology 11/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.